|
|
Gene : |
MS4A1 |
Gene ID : |
931 |
Uniprot ID : |
P11836 |
Alternative Name : |
MS4A1, CD20 |
Format : |
Purified |
Amount : |
100 µg |
Clone name : |
ABM46C7 |
Isotype : |
Mouse IgG2b Kappa |
Immunogen Information : |
A partial length recombinant protein corresponding to extra cellular domain of CD20 was used as the immunogen for this antibody. |
CD20 is clinically validated as an immunotherapy target for B-cell lymphomas and autoimmune diseases. CD20 consists of large, intracellular, amino- and carboxyterminal portions connected by 4 membrane-spanning domains. Its high expression on malignant B cells and its reported lack of shedding from the surface make CD20 an ideal target for antibody-mediated killing. Anti-CD20 antibodies are believed to mediate the therapeutic effect by activation of complement-dependent cytotoxicity (CDC) and largely by antibody-dependent cellular cytotoxicity exerted by recruitment of innate immune effector cells expressing the Fcgamma receptor IIIa.
Western blot analysis: 2-4 µg/ml
FACS : 0.5 µg / 10^6 cells